SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Hemosense Inc – ‘10-K’ for 9/30/06 – EX-32.1

On:  Tuesday, 12/26/06, at 8:23pm ET   ·   As of:  12/27/06   ·   For:  9/30/06   ·   Accession #:  1193125-6-259977   ·   File #:  1-32541

Previous ‘10-K’:  ‘10-K’ on 12/2/05 for 9/30/05   ·   Latest ‘10-K’:  This Filing

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

12/27/06  Hemosense Inc                     10-K        9/30/06    6:1.0M                                   RR Donnelley/FA

Annual Report   —   Form 10-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    813K 
 2: EX-10.12    Loan and Security Agreement No. 3821                HTML    102K 
 3: EX-23.1     Consent of Pricewaterhousecoopers LLP               HTML      6K 
 4: EX-31.1     Certification of CEO Pursuant to Section 302        HTML     12K 
 5: EX-31.2     Certification of CFO Pursuant to Section 302        HTML     12K 
 6: EX-32.1     Certification of CEO and CFO Pursuant to Section    HTML      8K 
                          906                                                    


EX-32.1   —   Certification of CEO and CFO Pursuant to Section 906


This exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



  Certification of CEO and CFO Pursuant to Section 906  

Exhibit 32.1

CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER

AND CHIEF FINANCIAL OFFICER PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, James Merselis, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Annual Report of HemoSense, Inc. on Form 10-K for the fiscal year ended September 30, 2006 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Annual Report on Form 10-K fairly presents in all material respects the financial condition and results of operations of HemoSense, Inc.

Date: December 26, 2006

 

/s/ James Merselis
James Merselis
President and Chief Executive Officer

I, Gordon Sangster, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Annual Report of HemoSense, Inc. on Form 10-K for the fiscal year ended September 30, 2006 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Annual Report on Form 10-K fairly presents in all material respects the financial condition and results of operations of HemoSense, Inc.

Date: December 26, 2006

 

/s/ Gordon Sangster
Gordon Sangster

Vice President of Finance and

Chief Financial Officer


Dates Referenced Herein

This ‘10-K’ Filing    Date    Other Filings
Filed as of:12/27/06None on these Dates
Filed on:12/26/06
For Period End:9/30/06
 List all Filings 
Top
Filing Submission 0001193125-06-259977   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Apr. 19, 10:24:42.1pm ET